481 related articles for article (PubMed ID: 36615513)
1. Repurposed Drugs in Gastric Cancer.
Araújo D; Ribeiro E; Amorim I; Vale N
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615513
[TBL] [Abstract][Full Text] [Related]
2. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
3. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
Fujitani K
Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
[TBL] [Abstract][Full Text] [Related]
4. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.
Miceli R; Tomasello G; Bregni G; Di Bartolomeo M; Pietrantonio F
World J Gastroenterol; 2014 Apr; 20(16):4516-25. PubMed ID: 24782604
[TBL] [Abstract][Full Text] [Related]
6. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
8. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
9. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
10. [Gastric cancer: (neo-)adjuvant treatment].
Fischbach W
Dtsch Med Wochenschr; 2012 Sep; 137(37):1822-4. PubMed ID: 22956228
[No Abstract] [Full Text] [Related]
11. Chemotherapy in gastric cancer.
Wöll E; Devries A; Eisterer W; Hejna M; Keil F; Stein H; Zacherl J; Greil R
Anticancer Res; 2008; 28(2B):1213-9. PubMed ID: 18505058
[TBL] [Abstract][Full Text] [Related]
12. What make differences in the outcome of adjuvant treatments for resected gastric cancer?
Nakajima T; Fujii M
World J Gastroenterol; 2014 Sep; 20(33):11567-73. PubMed ID: 25206264
[TBL] [Abstract][Full Text] [Related]
13. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
[TBL] [Abstract][Full Text] [Related]
14. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
15. [Conversion therapy of advanced gastric cancer].
Cheng X; Mao Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1127-1130. PubMed ID: 29130225
[TBL] [Abstract][Full Text] [Related]
16. Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy.
Coccolini F; Fugazzola P; Ansaloni L; Sartelli M; Cicuttin E; Leandro G; De' Angelis GL; Gaiani F; Di Mario F; Tomasoni M; Catena F
Acta Biomed; 2018 Dec; 89(8-S):104-109. PubMed ID: 30561427
[TBL] [Abstract][Full Text] [Related]
17. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].
Zhao DB; Zhang XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826
[TBL] [Abstract][Full Text] [Related]
18. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
[TBL] [Abstract][Full Text] [Related]
19. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
20. The role of chemotherapy in the current treatment of gastric cancer.
Van Cutsem E; Haller D; Ohtsu A
Gastric Cancer; 2002; 5 Suppl 1():17-22. PubMed ID: 12772882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
